Surfactant administration acutely affects cerebral and systemic hemodynamics and gas exchange in very-low-birth-weight infants

J Pediatr. 2004 Jun;144(6):809-14. doi: 10.1016/j.jpeds.2004.03.022.

Abstract

Objectives: To determine whether surfactant administration affects cerebral and systemic hemodynamics and gas exchange in very low birth weight infants and to determine the predominant factor influencing changes in mean cerebral blood flow velocity (mCBFv) after surfactant instillation.

Study design: Fourteen very low birth weight infants with respiratory distress syndrome had continuous monitoring of mCBFv, Paco(2), mean arterial blood pressure (MABP), and Pao(2) before, during, and after the second dose of surfactant. Peak values and relative changes of the 4 variables for 45 minutes after surfactant were calculated. Logistic regression was used to determine the predominant factor influencing changes in mCBFv after surfactant.

Results: Birth weight was 832 +/- 162 grams and gestational age was 25.7 +/- 1.5 weeks. The time from birth to monitoring was 6.9 +/- 1.0 hours. Mean CBFv increased 75.7% +/- 51.6% after surfactant and peaked at 14.4 +/- 5.9 minutes. Paco(2) was highly associated (OR=107.3, P <.0001) with mCBFv; as Paco(2) increased, mCBFv increased. In contrast, MABP (OR=6.7, P=.047) had less impact on mCBFv. Pao(2) was not associated with mCBFv.

Conclusions: The increases in mCBFv after surfactant administration were predominantly due to increases in Paco(2) and not changes in MABP.

Publication types

  • Clinical Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Blood Flow Velocity / drug effects
  • Blood Pressure / drug effects
  • Cerebrovascular Circulation / drug effects*
  • Female
  • Humans
  • Infant, Newborn
  • Infant, Very Low Birth Weight*
  • Logistic Models
  • Male
  • Pulmonary Gas Exchange / drug effects*
  • Pulmonary Surfactants / pharmacology*
  • Respiratory Distress Syndrome, Newborn / drug therapy*
  • Respiratory Distress Syndrome, Newborn / physiopathology

Substances

  • Pulmonary Surfactants